Notice of Iran-related Disclosure Filed Pursuant to Section 13(r)(3) of the Exchange Act (irannotice)
February 23 2021 - 2:25PM
Edgar (US Regulatory)
|
|
Fresenius Medical
Care
|
U.S. Securities and
Exchange Commission
|
|
AG &
Co. KGaA
|
100 F Street, N.E.
|
|
POB
|
Washington, DC 201549
|
|
61346 Bad Homburg
|
|
|
Germany
|
|
|
www.fmc-ag.com
|
|
|
|
|
|
February 23,
2021
|
|
Re:
|
Notice of Disclosure Filed in Exchange Act Annual Report Under Section 219 of the Iran Threat Reduction and Syria
Human Rights Act of 2012 and Section 13(r) of the Exchange Act
|
Ladies and Gentlemen:
Pursuant to Section 219 of the Iran
Threat Reduction and Syria Human Rights Act of 2012 and Section 13(r) of the Securities Exchange Act of 1934, as amended,
notice is hereby provided that Fresenius Medical Care AG & Co. KGaA has made disclosure pursuant to such provisions in
its Annual Report on Form 20-F for the fiscal year ended December 31, 2020, which was filed with the U.S. Securities
and Exchange Commission on February 23, 2021. Such disclosure begins on page 36 of the Annual Report on Form 20-F
and is incorporated by reference herein.
Sincerely,
By:
|
/s/ Helen Giza
|
|
|
Name:
|
Helen Giza
|
|
|
Title:
|
Chief Financial Officer
and
member of the Management Board
of the General Partner
|
|
|
Fresenius
Medical Care AG & Co. KGaA, 61346 Bad Homburg, Germany, T +49 6172 609-0, Registered Office and Commercial Register: Hof
an der Saale, HRB 4019, VAT-ID No.: DE 811127677, Chairman of Supervisory Board: Stephan Sturm General Partner: Fresenius
Medical Care Management AG, Registered Office and Commercial Register: Hof an der Saale, HRB 3894 Management
Board: Rice Powell (Chairman), Helen Giza, Dr. Katarzyna Mazur-Hofsäß, Dr. Olaf Schermeier, William Valle, Kent
Wanzek, Harry de Wit, Franklin W. Maddux. Bank Account: Commerzbank AG, Frankfurt/Main, IBAN: DE23 5008 0000 0711 6731
00, SWIFT/BIC: DRESDEFF501
member of the Management Board
of the General Partner
Fresenius Medical Care (NYSE:FMS)
Historical Stock Chart
From Mar 2024 to Apr 2024
Fresenius Medical Care (NYSE:FMS)
Historical Stock Chart
From Apr 2023 to Apr 2024